This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo
Back to library search

Watching the Dominoes Fall - A Case Study in Preparedness for Increased Regulation in the Cosmetics Industry

Abstract

Recent developments in the EU regulatory environment for consumer products illustrate the need for in-house regulatory and legal professionals to embed themselves in the product development and regulatory processes of their business organizations. Regulatory changes in one jurisdiction most often will have global supply chain implications which, if not managed optimally, can cost businesses unnecessary amounts of time and money. Particularly for smaller businesses with a global reach, compliance with multiple and seemingly inconsistent regulatory requirements present a financial burden and the distraction of resources from new business growth. Moreover, a new regulatory regime in one jurisdiction may signal similar impending changes in other jurisdictions that are prudent to consider even before enactment. Using as an example EU Regulation No. 1223/2009 on cosmetic products, which has a compliance deadline of July 2013, valuable lessons can be learned concerning the development and implementation of a compliance strategy that minimizes the financial and manpower burden on the business by anticipating differing regulatory requirements in multiple jurisdictions.

Author

Portrait image of Brian Foley
Brian Foley
Vice President, General Counsel & Director, NeoStrata Company, Inc., USA

Brian is the Vice President, General Counsel and a Director of NeoStrata Company, Inc., a Princeton, New Jersey based developer, manufacturer and marketer of a comprehensive range of clinically-proven, dermatologist developed skin care brands including NeoStrata, Exuviance, CoverBlend, NeoCeuticals and NeoStrata Therapeutics. NeoStrata products are available globally in retail outlets, physicians' offices and spas in over 78 countries. Prior to joining NeoStrata, Brian was the managing partner at a boutique corporate firm based in New York, NY where he litigated cases and counseled clients on a variety of corporate and intellectual property issues. He also has extensive experience in intellectual property protection and in devising and implementing strategies to maximize the economic value of intellectual property assets. He is a 1984 cum laude graduate of New York Law School where he was a member of the Law Review. Brian is published on topics relating to patent enforcement as a means of maximizing intellectual property assets and other legal issues of interest. He was also a partner in a venture capital firm focusing on investments in start-up technology pioneers. Brian is admitted to practice in New York, Connecticut, numerous trial federal courts and courts of appeal.

Company

NeoStrata Company, Inc. logo

NeoStrata Company, Inc.

NeoStrata Company, Inc. is a Princeton, NJ based innovator in dermatologist developed therapeutic and cosmetic skin care products. www.neostrata.com. NeoStrata develops, manufactures and markets a comprehensive range of clinically-proven, dermatologist developed skin care brands including NeoStrata, Exuviance, CoverBlend, NeoCeuticals and NeoStrata Therapeutics. NeoStrata products are available globally in retail outlets, physicians' offices and spas in over 75 countries.

Related Papers

Needs, Challenges, and Obstacles in the Implementation of the EU Medical Device Regulation
The Medical Device Regulation (MDR) 2017/745 is a novel piece of legislation intended to govern the high-tech commercial domain of medical devices in the European Union to the highest possible...Read more
Portrait image of Tancredi Vergani
Tancredi Vergani
Consultant, Obelis Group, Belgium
Portrait image of Carlos Francisco  Marin Barrios
Carlos Francisco Marin Barrios
Consultant, Obelis Group, Belgium
The Misuse of the FCA to Enforce cGMP (Current Good Manufacturing Practice) Violations
Since the civil False Claims Act (“FCA”) was amended in 1986, the statute has evolved into a seemingly limitless weapon for enforcing other statutes and regulations applicable to every industry...Read more
Portrait image of Kyle Faget
Kyle Faget
Compliance Counsel, Global Compliance, Boston Scientific Corporation, USA
“The US innovates, China replicates, Europe regulates” What is the role of general counsel in this scenario?
The US innovates, China replicates, and the EU regulates is a punchline in the policy debate; but beyond whether it is true or not there is certainly a tendency in...Read more
Portrait image of Alfonso Levote
Alfonso Levote
General Counsel & Investor Relations, Rosetti Marino S.p.A., Italy
Impact of Financial Regulations on Information and Communication Technology Providers
The digitalization of financial services is supporting the simplification of day-to-day life, making financial services available round the clock and easily accessible to the most remote parts of the globe....Read more
Portrait image of Andreas Gustafsson
Andreas Gustafsson
Senior Advisor, Nasdaq, Sweden
Portrait image of Sofia Skroubi
Sofia Skroubi
Senior Associate General Counsel, Nasdaq , Sweden